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Background: The tradition of consuming alcohol has long been a part of Italian culture and is responsible for a
large health burden. This burden may be reduced with effective interventions, one of the more important of which
is treatment for Alcohol Dependence (AD). The aim of this article is to estimate the burden of disease in Italy
attributable to alcohol consumption, heavy alcohol consumption, and AD. An additional aim of this paper is to
examine the effects of increasing the coverage of treatment for AD on the alcohol-attributable burden of disease.
Methods: Alcohol-attributable deaths and the effects of treatments for AD were estimated using alcohol-
attributable fractions and simulations. Deaths, potential years of life lost, years lived with disability, and disability
adjusted life years lost were obtained for 2004 for Italy and for the European Union from the Global Burden of
Disease study. Alcohol consumption data were obtained from the Global Information System on Alcohol and
Health. The prevalences of current drinkers, former drinkers, and lifetime abstainers were obtained from the GENder
Alcohol and Culture International Study. The prevalence of AD was obtained from the World Mental Health Survey.
Alcohol relative risks were obtained from various meta-analyses.
Results: 5,320 deaths (1,530 female deaths; 3,790 male deaths) or 5.9% of all deaths (4.9% of all female deaths; 6.3%
of all male deaths) of people 15 to 64 years of age were estimated to be alcohol-attributable. Of these deaths,
74.5% (61.3% for females; 79.8% for males) were attributable to heavy drinking, and 26.9% (25.6% for females; 27.5%
for males) were attributable to AD. Increasing pharmacological AD treatment coverage to 40% would result in an
estimated reduction of 3.3% (50 deaths/year) of all female and 7.6% (287 deaths/year) of all male alcohol-
attributable deaths.
Conclusions: Alcohol was responsible for a large proportion of the burden of disease in Italy in 2004. Increasing
treatment coverage for AD in Italy could reduce that country’s alcohol-attributable burden of disease.
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Alcohol consumption plays a large traditional role in all
European countries; however, not all countries (and re-
gions) have similar drinking cultures and drinking trends.
In contrast to other regions in Europe that have more
detrimental patterns of alcohol consumption, Italy has a
Mediterranean drinking culture, which features regular
consumption of alcohol with a large prevalence of daily
drinkers who often consume alcohol with meals. Italian
culture also has a high tolerance of the social outcomes of
drinking, but has no tolerance for public drunkenness [1,2].
One of the most severe health consequences of alcohol
consumption is Alcohol Dependence (AD). The Diagnos-
tic and Statistical Manual of Mental Disorders (version
IV) (DSM IV) defines AD as a maladaptive use of alcohol
with clinically significant impairment as manifested by at
least three of the following criteria within any one year
period: tolerance; withdrawal; taken in greater amounts or
over a longer time course than intended; desire or unsuc-
cessful attempts to cut down or control use; social, occu-
pational or recreational activities given up or reduced;
and/or continued use despite knowledge of physical or
psychological consequences of that use [3]. In 2009 65,310
people with AD attended an alcohol treatment program in
Italy The women/men ratio was 1: 3.7 [4]. Overall, the
proportion of people with AD in treatment in 2009 was
less than 10%, based on AD prevalence estimates for Italy
published by Scafato and colleagues [5]. The proportion of
people with AD who are being treated for AD is very simi-
lar to the European average [2].
The number of services in Italy for the treatment of AD
(which are presently primarily community services) has in-
creased from 280 in 1996 to 514 in 2009 [4]. Treatment for
AD in Italy is based more on a psychosocial or an edu-
cational approach than on pharmacological treatment;
pharmacological treatment was used in only 28.8% of treat-
ment cases in 2009 [4]. Prescribed drugs were sodium
oxibate (gamma hydroxybutyrate), metadoxine, disulfiram,
and chlordiazepoxide, and occasionally naltrexone and
acamprosate. During 2001 to 2009 counselling was used in
26.5% of AD treatment cases, psychosocial advice (14.5%),
self-help groups (Alcoholics Anonymous, 7%), inpatient
short treatment (5%), and therapeutic community (2.7%).
Collaboration between alcohol addiction services and
self-help groups [4], namely Alcoholics Anonymous (AA)
or Club of Treated Alcoholics (CAT) [6], is common, af-
fecting 50% of cases, even if such addiction services refer
formally to these groups in only 7% of cases.
Given that the coverage of treatment for AD in Italy is
currently estimated to be less than 10%, the burden of
alcohol consumption in Italy may be reduced if coverage
for AD in Italy were increased. Accordingly, the aim of
this article is to calculate for Italy for 2004 the alcohol-
attributable burden of disease caused by alcoholconsumption, heavy alcohol consumption, and AD, and
to estimate the effects of increasing the coverage of AD
treatments on the alcohol-attributable burden of disease.
Methods
Alcohol consumption data
Data for per capita consumption of alcohol were
obtained from a government survey of the World
Health Organization and the Global Information System
on Alcohol and Health [7,8]. Data for the prevalence of
current drinkers (people who have consumed at least
one standard drink of alcohol in the past year), former
drinkers (people who have consumed at least one stand-
ard drink of alcohol, but did not do so in the past year),
and lifetime abstainers (people who have never con-
sumed at least one standard drink) were obtained from
the GENder Alcohol and Culture International Study
(GENACIS) survey [9,10]. The Italian GENACIS survey
was a national telephone survey conducted in 2000
which sampled a total of 1000 people (514 women and
486 men).
To correct for the undercoverage of alcohol consump-
tion measured in surveys [11], we triangulated the survey
data with data on per capita consumption using methods
published by Rehm and colleagues (see [12,13] for full
details of the mathematical models). For this method, we
used 80% of adult per capita consumption when model-
ling alcohol consumption in order to account for alcohol
not consumed and for undercoverage present in observa-
tional studies that the Relative Risks (RRs) used in the
meta-analyses are based upon [12,13]. This triangulation
method assumes that the alcohol consumption distri-
bution will follow a Gamma distribution [12,13]. The first
step in this method is the calculation of sex- and age-
specific mean alcohol consumption using population
level alcohol consumption data (obtained from per capita
consumption estimates), data on the prevalence of current
drinkers (obtained from population surveys), and the sex
and age relative amounts of alcohol consumed (obtained
from population surveys). The second step is the calcula-
tion of the scale parameter of the alcohol consumption
Gamma distribution for each age and sex group. The scale
parameter is calculated using the association between the
mean alcohol consumption and the variance of a popula-
tion level alcohol consumption Gamma distribution (as
described by Kehoe and colleagues [12]).
Patterns of alcohol consumption
The prevalence of binge alcohol consumption for 2009
(5 or more drinks on one occasion for men (60 grams of
pure alcohol or more) and 4 or more standard drinks on
one occasion for women (48 grams of alcohol or more))
was based on the pattern of drinking score [14]. The
prevalence of irregular binge drinking for 2009 was
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In the European Commission report, the prevalence of
binge alcohol consumption was defined as consuming
more than 5 alcoholic drinks per occasion.
Heavy alcohol consumption was defined as consuming
on average more than 60 grams of alcohol per day for men
(the equivalent of consuming 5 drinks or more) and more
than 40 grams of alcohol per day for women (the equivalent
of consuming 3 and 1/3 standard drinks or more).
The pattern in which alcohol is consumed at the popu-
lation level is best summarized by the metric known as
the pattern of drinking score, which is a composite meas-
ure assessing the manner in which individuals consume
alcohol, and which was developed as part of the Compara-
tive Risk Assessment study within the Global Burden of
Disease (GBD) study [16,17]. The 2005 pattern of drinking
score for Italy was obtained from the 2005 GBD study.
Data on alcohol dependence
Data on AD for Italy was obtained from a publication
authored by Scafato and colleagues [5]. Additional data
on AD for Italy, Southern Europe, and the European
Union (EU) were obtained from the World Mental
Health Survey (ESEMeD/MHEDEA 2000 Investigators,
2004; [18]). These data likely underestimate the true
population prevalence of AD, as questions used to meas-
ure AD in the World Mental Health Survey were only
asked of those respondents who scored positively on
questions relating to alcohol abuse [19]. To correct for
this undercoverage, data from the World Mental Health
Survey were combined with data from the German Men-
tal Health Survey, where both dependence and abuse
were assessed independently [20,21]. Sensitivity analyses
were performed using AD prevalence estimates data
from Lepine and colleagues [22]. These estimates of AD
are from the same source as for the main analysis, but
were not corrected for undercoverage. Additionally,
sensitivity analyses were performed using the corrected
estimates from the World Mental Health Survey for
southern Europe (Cyprus, Greece, Italy, Malta, Portugal
and Spain) and the EU.
Modelling alcohol-attributable mortality and morbidity
To calculate the alcohol-attributable burden of disease, we
utilized Alcohol-Attributable Fractions (AAFs), where an
AAF is defined as the percentage of mortality that would
not occur if everyone was a lifetime abstainer. For diseases
and conditions which are entirely attributable to alcohol
consumption (i.e. where alcohol is a necessary cause in
the development of the disease or condition, such as AD),
the AAF is equal to 1; however, for alcohol-related
diseases, conditions and injuries where alcohol is not a
necessary cause, we calculated the AAFs by combining ex-
posure indicators and RR functions. (See [2] for the AAFcalculation methodology for total alcohol consumption,
heavy alcohol consumption, and AD, and see Additional
file 1 for the sources of all RR functions for each disease
modelled). It should be noted that the number of deaths
due to heavy alcohol consumption and AD overlap as
most people with AD are also heavy consumers of alcohol.
Modelling the effects of treatment for alcohol
dependence
To estimate the effects of increasing AD treatment rates
on alcohol-attributable mortality, we simulated the ef-
fects of an increase in the coverage of AD treatment,
assuming 40% of all people with AD were receiving
treatment. For these simulations, we examined the ef-
fects of increasing the AD treatment coverage for five
different treatments: Acamprosate and opioid antago-
nists therapy (referred to in this paper as pharmaco-
logical treatment) [23,24], Motivational Interviewing/
Cognitive Behavioral Therapy (MI/CBT) [25,26], MI/
CBT assuming the upper level of effectiveness, and Brief
Interventions (BI) (in two different hospital settings)
[27]. Additional file 2 outlines the assumptions used
when modelling the effects of AD treatments on alcohol
consumption and mortality (see also [2,28]).
For our simulation model, we generated 100,000 data
points or “drinkers” to represent the drinking population
of Italy using the Gamma distribution as described above.
The data points that were identified as drinkers with AD
were selected randomly among people who drink more
heavily (men who consume 72 grams or more of pure al-
cohol per day and women who consume 48 grams or
more of pure alcohol per day), with the total number of
data points selected being equal to the number of people
in Italy with AD among every 100,000 drinkers. As the
effect of treatment interventions can be translated into a
shift in average alcohol consumption or as a decrease in
the RR of mortality, the effects of interventions were cal-
culated using AAFs. The AAFs were evaluated before and
after interventions and the differences between the esti-
mates were used to calculate the deaths prevented for
each given increase in treatment coverage.
The number of alcohol-attributable deaths was calcu-
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where “cause_a” represents a given alcohol-related cause of
death; and “n_a” represents the total number of alcohol-
related diseases for which the alcohol-attributable mortality
was calculated (see Additional file 2). “Mortalitycause_a” rep-
resents the mortality for cause “a”; “N_b” represents the
number of people who do not have AD (“b”); and “N_c”
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pendent (“c”). “RRNorm_a(x)Norm_b” represents the RR for
the alcohol-related disease or condition “a” given an aver-
age daily alcohol consumption of x for person “b”; and
“RRAD_a(x)AD_c” represents the RR for the alcohol-related
disease or condition “a” given an average daily alcohol
consumption of x for person “c”. For people with AD, the
RR function was estimated by multiplying the general
population RR by 2 to account for the overall higher mor-
tality risk of people with AD [29].
Mortality and morbidity data
Data on the number of deaths, Potential Years of Life Lost
(PYLL), Years Lived with Disability (YLD), and Disability
Adjusted Years of Life (DALYs) lost by cause for 2004
were obtained from the 2004 GBD Study [30].
Population data
Data on population estimates for Italy and for other
European countries for 2005 were obtained from the
2005 GBD study [31].
Software
All analyses were performed using R version 2.13.0 [32]
and Mathematica version 8 [33].
Ethics
As this analysis was performed on data already collected
ethics approval was not required from the Centre for
addiction and Mental Health. During the original studies
(which this analysis is based on) written informed consent
was obtained from participants for publication reports
based on secondary data analysis.
Results
Alcohol consumption in Italy
Italy’s adult per capita consumption in 2009 was 9.6 li-
tres (l) of pure alcohol (2.4 l unrecorded consumption;
7.2 l recorded consumption), which was significantly
lower than the EU average of 12.5 l of pure alcohol. Of
the 7.2 l of recorded consumption, wine was by far the
most frequently consumed beverage, constituting 73% of
all recorded alcohol consumed. Beer was the second
most frequently consumed alcoholic beverage, constitut-
ing 22% of all recorded alcohol consumed, and spirits
were the third most frequently consumed alcoholic bev-
erage, constituting 5% of all recorded alcohol consumed.
Figure 1 illustrates trends in recorded alcohol consump-
tion in Italy from 2000 to 2009 by beverage type (based
on 3-year averages with the consumption in a given year
calculated by averaging the recorded adult per capita
consumption that year, the following year and the previ-
ous year). Recorded adult per capita alcohol consump-
tion decreased from 2000 to 2009, dropping from justover 9 l of pure alcohol in 2000 to just over 7 l of pure
alcohol in 2009, which can be attributed to a decrease in
recorded wine consumption (see Additional file 3).
Italy had a pattern of drinking score of 1 in 2009 (the
least detrimental score possible). For people aged 15 to
64 years of age in Italy in 2009, an estimated 4.6% of
men and 9.9% of women were lifetime abstainers, 3.1%
of men and 4.4% of women were former drinkers, and
92.3% of men and 85.7% of women were current
drinkers. Among current drinkers, 12.4% of male current
drinkers and 7.7% of female current drinkers were con-
sidered to be heavy consumers of alcohol. In 2009 the
prevalence of irregular binge drinking in Italy was esti-
mated to be 14% for binge drinking approximately once
a week and was estimated to be 8% for binge drinking
approximately once a month.
Alcohol dependence in Italy
Scafato and colleagues estimated the prevalence of AD in
Italy to be 0.9% for women and 3.1% for men. This pre-
valence estimate corresponds to 165,000 women and
612,000 men aged 15 to 64 years of age. Using data from
the ESEMeD study (corrected for underestimation), we
estimated that 93,600 women and 149,800 men 18 to
64 years of age in Italy have AD, which corresponds to a
prevalence estimate for AD of 0.5% of all women and 0.8%
of all men. For comparison purposes, using corrected data
from the ‘ study, we estimated that the prevalence of AD
for Southern Europe was 0.6% for women and 1.7% for
men, and that the prevalence of AD for the EU was 1.3%
for women and 4.8% for men.
Alcohol-attributable harms
In Italy 5,320 deaths (1,530 female deaths; 3,790 male
deaths) of people 15 to 64 years of age were attributable to
alcohol in 2004. On average, 7.6 deaths of women and
19.0 deaths of men, per 100,000 people (15 to 64 years of
age), were estimated to be attributable to alcohol con-
sumption in 2004, placing Italy 24th out of the 30 coun-
tries analyzed (the EU countries plus Iceland, Norway and
Switzerland). Alcohol consumption was responsible for
4.9% of all deaths of women and 6.3% of all deaths of men,
placing Italy 23rd and 26th, respectively out of the above-
mentioned 30 analyzed countries (see Figure 2). Thus,
even though the toll of drinking on mortality is relatively
low by EU standards, approximately 1 in every 20 women
and 1 in every 16 men were estimated to have died prema-
turely due to alcohol-attributable causes (Figure 2).
In Italy 118,100 DALYs (28,000 female DALYs; 90,100
male DALYs) for people 15 to 64 years of age were attri-
butable to alcohol in 2004. In Italy, 146 DALYs for women
and 460 DALYs for men, per 100,000 people (for people
15 to 64 years of age) were estimated to be attributable to
alcohol in 2004, placing Italy 28th and 30th for women
Figure 1 Trends in recorded alcohol consumption in Italy since 2000 (data obtained from the Global Information System on Alcohol
and Health [7,8]).
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countries. The percentage of the total health burden
attributable to alcohol as measured in DALYs was 1.6%
for women (rank: 28th) and 4.5% for men (rank: 30th)
in 2004. Again, while the relative level of burden ofFigure 2 The percentage of deaths attributable to alcohol consumptidisease is low compared to other European countries,
the absolute level is relatively high.
Figure 3 outlines the percentage of all deaths that are
attributable to heavy alcohol consumption in Italy in
2004 for men and women. 4.4% (3.0% for women andon by country for: A) women, and B) men.
Figure 3 The percentage of deaths attributable to heavy alcohol consumption by country for: A) women, and B) men.
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drinking for people 15 to 64 years of age. Thus, heavy
drinking was responsible for 74.5% of the alcohol-
attributable deaths (61.3% for women and 79.8% for men).
In Italy 390 female deaths and 1043 male deaths for
people 15 to 64 years of age were attributable to AD in
2004. This corresponds to 1.6% (1.3% for females; 1.7% for
males) of all deaths for people 15 to 64 years of age being
attributable to AD in Italy. Of the total number of
alcohol-attributable deaths, 26.9% (25.5% for females;
27.5% for males) of these deaths were attributable to AD.
Effects of potential treatment interventions
Table 1 outlines the results of simulating the treatment
of 40% of people with AD under varying assumptions of
AD prevalence and the type of treatment. We observed
that the most effective intervention in Italy (if coverage
rates were increased to 40%) was pharmacological treat-
ment. If 40% of people with AD in Italy underwent
pharmacological treatment in 2004, 3.3% of female
alcohol-attributable deaths and 7.6% of male alcohol-attributable deaths would not have occurred. The second
most effective treatment was BI, with 2.9% of female
alcohol-attributable deaths and 7.4% of male alcohol-
attributable deaths not occurring if 40% of people with
AD in Italy were treated in that manner.
For our sensitivity analysis, we observed that pharmaco-
logical treatment was the most effective intervention for
both men and women (at a coverage rate of 40%) regard-
less of the estimated prevalence of AD. We observed that
the percentage of alcohol-attributable deaths that would
not have occurred if 40% of people with AD were treated
with pharmacological treatment would be 2.7% for women
and 3.5% for men if we used the AD prevalence estimates
from the Scafato and colleagues study, 4.6% for women
and 13.8% for men if we used the AD prevalence estimates
for Southern Europe, and 7.9% for women and 21.9% for
men if we used the AD prevalence estimates for the EU.
In general, we observed that the greater the estimated
prevalence of AD, the greater the number of deaths that
would not have occurred if coverage of AD treatment was
at a level of 40%. This relationship was linear and was
observed for all five interventions.
Table 1 The number and percentage of alcohol-attributable deaths in Italy that would not have occurred in 2004 if the















AD estimate Women Men Women Men Women Men Women Men Women Men
Deaths avoided Italy (ESMeD study) 50 287 34 130 40 153 32 126 44 279
Italy [5] 42 131 28 63 29 74 26 62 37 133
Southern Europe
(ESMeD study)
70 523 50 239 59 280 43 232 65 511




Italy (ESMeD study) 3.3% 7.6% 2.2% 3.4% 2.6% 4.0% 2.1% 3.3% 2.9% 7.4%
Italy [5] 2.7% 3.5% 1.8% 1.7% 1.9% 2.0% 1.7% 1.6% 2.4% 3.5%
Southern Europe
(ESMeD study)
4.6% 13.8% 3.3% 6.3% 3.9% 7.4% 2.8% 6.1% 4.2% 13.5%
EU (ESMeD study) 7.9% 21.9% 5.5% 10.3% 6.6% 12.1% 5.3% 10.1% 7.1% 22.0%
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In 2004 alcohol consumption in Italy was responsible for
approximately 5,320 deaths (1,530 female deaths; 3,790
male deaths) or 5.9% of all deaths (4.9% of all female
deaths; 6.3% of all male deaths). Although low when
compared to the rest of the EU, given the magnitude of
the alcohol-attributable burden of disease in Italy, it is
imperative to assess the effectiveness of policies and in-
terventions that can reduce this burden.
AD is responsible for 26.9% of the alcohol-attributable
burden of disease in Italy; however, the current AD
treatment coverage rate for Italy is low, with less than
10% of people with AD being treated [5]. Accordingly,
one area for improvement would be to increase treat-
ment coverage rates for individuals with AD [2,28]. In
particular, if coverage of pharmacological AD treatment
(observed to be the most effective form of treatment)
were to increase to 40% of all people with AD, we
estimated the resulting prevention of 3.3% (50 deaths) of
all female and 7.6% (287 deaths) of all male alcohol-
attributable deaths in 2004 in Italy. The introduction of
BI in hospitals would result in the prevention of a sub-
stantial number of deaths, as people in hospitals have a
higher risk of mortality, and reducing alcohol consump-
tion within this population group would have a greater
effect in reducing mortality than if this form of inter-
vention was administered to the general population;
according to the latest Cochrane analyses, the mortality
rate was reduced by 40% within 1 year of the BI treat-
ment intervention [27].
Psychotherapy, sometimes combined with pharma-
cotherapy, is the most common type of AD therapy in
Italy. The most commonly used psychotherapeutic pro-
cedures (from most frequent to less frequent) are MI,
self-help group facilitation, BI, CBT, and psychodynamic
interventions (based on unpublished study findings).Based on our findings, increasing the proportion of
people with AD who undergo pharmacological treat-
ment could help to reduce the alcohol-attributable bur-
den of disease in Italy. Furthermore, it is notable that
the treatment coverage rate for depression (another
neuropsychiatric disorder) has been increased to 40% in
developing nations and, thus, a 40% treatment coverage
rate for AD may be feasible [34].
It should be noted that the feasibility costs and time to
increase the coverage rate of AD treatment to 40% are
not assessed in this article. We also did not compare the
cost effectiveness of increasing the AD coverage rate to
40% with general population interventions that aim to
reduce population consumption, as cost estimates for in-
creasing AD therapy are not available.
Limitations
Our analysis has certain limitations. Information
concerning the cause of death has been shown to con-
tain inaccuracies [35], with recent studies confirming
considerable degrees of error in such information
[36,37]. To minimize the error from the unreliable
nature of mortality data, especially for people older than
64 years of age, we excluded individuals who were
65 years or older when performing our analyses.
Exposure estimates for drinking status and binge
drinking patterns used in our analysis were measured in
2009, whereas deaths, PYLL, YLD and DALYs were
measured in 2004. The short length of time between
2004 and 2009 should not greatly affect the alcohol-
attributable mortality estimates for Italy, as alcohol
consumption in Italy has only decreased slightly during
this time period [7]; however, this slight decrease in con-
sumption may lead to an underestimation of the number
of alcohol-attributable deaths and deaths attributable to
AD in 2004. The estimates of alcohol consumption used
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currently with deaths). Since long-term patterns of alcohol
consumption impact the risk of some chronic diseases,
such as cancer, there will be resulting inaccuracies in the
number of some chronic disease deaths [38]. Furthermore,
our analysis did not include aspects of harms to others
(such as motor vehicle accidents, and assaults), which re-
cently have been shown to constitute a large proportion of
the burden of injury attributable to alcohol [39].
Additionally, the mortality data, AD prevalence data,
and AD treatment coverage data used in our analysis was
not available for regions within Italy. Thus, our analysis
was limited as we could not estimate the variability in the
burden of alcohol consumption, heavy alcohol consump-
tion and AD; and the potential number of deaths that
would have been avoided if the treatment coverage was in-
creased to 40% of all people with AD in 2004 for regions
within Italy as alcohol consumption in Italy has been
shown to vary, the effect of increasing treatment coverage
for AD should vary by region in Italy [40]. Additionally,
the data on alcohol dependence RRs were not estimated
by age and, thus, an analysis of increasing AD treatment
coverage rates by age was not possible.
The mortality data used in our analysis did not have a
measure of uncertainty and, accordingly, our analysis
was unable to provide 95% confidence intervals for the
number of deaths that could have been avoided in 2004
if the treatment coverage of AD was increased to 40%.
Additionally, the measures used in this analysis to esti-
mate the number of deaths that would have been avoided
in 2004 if the treatment coverage rate of people with AD
increased to 40% have random error associated with them,
and, thus, these estimates do have some uncertainty that
is not reported in this paper.
The RRs used in this study for general causes also have
inaccuracies. First, observational studies that measured
the alcohol RR are susceptible to the underreporting of
alcohol consumption [41]. To account for this, we mod-
elled alcohol consumption using 80% of adult per capita
consumption to account for alcohol not consumed and
the underreporting of alcohol consumption in observa-
tional studies [12,13]. Second, most analyses on the risk
of alcohol-related conditions do not distinguish between
incidence-based alcohol RRs and mortality- based alcohol
RRs; the RRs for mortality and morbidity from alcohol-
related conditions differ in some cases which may lead to
our results being underestimates (as morbidity alcohol
RRs are often lower than mortality alcohol RRs [42]).
Third, the RR functions used in our analysis are adjusted;
however, the AAF formulas were designed for unadjusted
RR functions. When alcohol RR functions are adjusted for
the usual confounders, the adjusted RRs are not noticeably
different when compared to unadjusted RRs, and, thus,
the use of adjusted RRs will not noticeably affect estimatesof alcohol-attributable mortality (see [43] for an in-depth
discussion of using adjusted alcohol RRs to calculate
alcohol-attributable mortality).
In Italy long-term γ-hydroxybutyric acid (ghb), nal-
trexone, and disulfiram are used as main treatments for
alcohol dependence [4]; however, there are unfortu-
nately not enough trials of these medications for a com-
prehensive meta-analysis and, thus, we only modelled
the effects of acamprosate and opioid antagonists the-
rapy. We expect that the conclusions of this study
would not change tremendously with other medications
as examples, if based on a large number of trials. In
addition, the current model of acamprosate and opioid
antagonists therapy allows for comparisons with other
European countries, such as Spain [44].
Conclusions
Alcohol consumption is a major risk factor for mortality
in Italy. More substantial alcohol policies and improved
coverage of pharmacological treatment for people with
AD could reduce alcohol consumption and the resulting
burden of disease. Effective improvement of the cover-
age rates of AD treatments in Italy would result in the
prevention of a large number of alcohol-attributable
deaths since AD treatment coverage rates are estimated
to be very low. Thus, implementing measures aimed at
reducing alcohol consumption and increasing AD treat-
ment coverage rates should be considered by policy
makers in Italy in order to reduce the country’s large
alcohol-attributable burden of disease.
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